• 6856 Citations
  • 38 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Biana Godin earned her Ph.D. in Pharmaceutical Sciences from the Hebrew University of Jerusalem in 2006. During her Ph.D. studies, Dr. Godin focused on designing a non-invasive treatment for the hard-to-treat skin deep infections and on nasal delivery of proteins. She was recruited as a Postdoctoral trainee in the field of Cancer Nanotechnology to the University of Texas Health Sciences Center. Her postdoctoral research focused on injectable multistage nanovectors (MSVs) for cancer treatment and imaging. Her work provided insightful understanding of the interactions of MSVs with immune cells in vivo and in vitro, biocompatibility of MSV, effect of geometry and targeting moieties on MSV biodistribution, and evaluation of MSV systems as near-infra red and MRI imaging agents. In October 2010, Dr. Godin joined the Department of Nanomedicine at the Research Institute. 

Research in Dr. Godin's lab, largely funded by federal and foundation grants, focuses on developing physiologically relevant in vitro and in vivo disease models and exploiting physical and biological mechanisms to improve currently available therapeutic options in oncology and obstetrics. Dr. Godin considers herself a translational scientist on the interception of biological and physical sciences, with the ultimate goal of bringing advanced and safe therapies and the techniques to personalize therapies into the clinic to benefit patients.

Dr. Godin has more than 200 scientific publications, received multiple federal and foundation-based grants and participated in multiple national and international grant review panels. 

Dr. Godin and her group published numerous peer-reviewed articles, book chapters and reviews in top journals including Nature Nanotechnology, Advanced Functional Materials, Journal of Controlled Release and Cancer Research. She also received national and international awards and other recognitions for her work and is on the editorial board and review board for numerous journals. 

Research interests

Dr. Godin's research focuses primarily on the following areas:

-Employing principles of nanomedicine in Ob/Gyn

-Targeting liver metastasis with advanced nanocarriers

-Novel strategies to target tumor microenvironment

-Advanced patient-derived ex vivo disease models for personalized therapies

The main objective of these studies is to provide innovative approaches to treatment and diagnosis of cancer and Ob/Gyn disorders. 

Education/Academic qualification

Pharmaceutics, Postdoctoral Fellowship, The Hebrew University of Jerusalem

Pharmaceutical Sciences, PhD, The Hebrew University of Jerusalem

MSc Pharm, The Hebrew University of Jerusalem

Nanomedicine, Postdoctoral Fellowship, University of Texas Health Science Center

External positions

Adjunct Assistant Professor, Obstetrics and Gynecology, University of Texas Health Sciences Center, Houston

Sep 1 2017 → …

Adjunct Assistant Professor, Department of Electrical and Computer Engineering, University of Houston

Adjunct Assistant Professor, University of Texas Graduate School of Biomedical Sciences at Houston

Free-text keywords

  • Nanomedicine
  • Cancer
  • Ob/Gyn
  • Nano-therapeutics targeting
  • Physical sciences in oncology

Research Area Keywords

  • Cancer
  • Nanomedicine
  • Precision Medicine

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease

Leonard, F., Srinivasan, S., Liu, X., Collnot, E. M., Ferrari, M., Lehr, C. M. & Godin, B., Jun 1 2020, In : European Journal of Pharmaceutics and Biopharmaceutics. 151, p. 61-72 12 p.

Research output: Contribution to journalArticle

  • Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization

    Leonard, F., Curtis, L. T., Hamed, A. R., Zhang, C., Chau, E., Sieving, D., Godin, B. & Frieboes, H. B., May 1 2020, In : Cancer Immunology, Immunotherapy. 69, 5, p. 731-744 14 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Increased soluble crkl in serum of breast cancer patients is associated with advanced disease

    Srinivasan, S. & Godin, B., Jul 2019, In : Cancers. 11, 7, 961.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Pre-existing H4K16ac levels in euchromatin drive DNA repair by homologous recombination in S-phase

    Horikoshi, N., Sharma, D., Leonard, F., Pandita, R. K., Charaka, V. K., Hambarde, S., Horikoshi, N. T., Gaur Khaitan, P., Chakraborty, S., Cote, J., Godin, B., Hunt, C. R. & Pandita, T. K., Dec 1 2019, In : Communications Biology. 2, 1, 253.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma

    Borsoi, C., Leonard, F., Lee, Y., Zaid, M., Elganainy, D., Alexander, J. F., Kai, M., Liu, Y. T., Kang, Y., Liu, X., Koay, E. J., Ferrari, M., Godin, B. & Yokoi, K., Sep 10 2017, In : Cancer Letters. 403, p. 296-304 9 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    Prizes

    'ATCC Excellence Photograph Award’ for scientific content and image quality

    Godin, Biana (Recipient), 2014

    Prize: Prize (including medals and awards)

  • FASEB 2013 BioArt Competition

    Godin, Biana (Recipient), 2013

    Prize: Other distinction